UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005702
Receipt number R000006741
Scientific Title A phase II study of maintenance S-1 after induction therapy of platinum doublet chemotherapy in patients with squamous cell carcinoma of the lung
Date of disclosure of the study information 2011/06/01
Last modified on 2019/06/14 15:34:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase II study of maintenance S-1 after induction therapy of platinum doublet chemotherapy in patients with squamous cell carcinoma of the lung

Acronym

A phase II study of maintenance S-1 after induction therapy of platinum doublet chemotherapy in patients with squamous cell carcinoma of the lung

Scientific Title

A phase II study of maintenance S-1 after induction therapy of platinum doublet chemotherapy in patients with squamous cell carcinoma of the lung

Scientific Title:Acronym

A phase II study of maintenance S-1 after induction therapy of platinum doublet chemotherapy in patients with squamous cell carcinoma of the lung

Region

Japan


Condition

Condition

squamous cell carcinoma of the lung

Classification by specialty

Pneumology Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Clinical usefulness of maintenance S1 after induction therapy of platinum doublet chemotherapy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

PFS

Key secondary outcomes

RR(Maintenance),OS(MST),
compliance (Maintenance),
TS, DPD OPRT(5-Fu related molecules)
AE


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

S-1 Maintenance

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1. Sqamous cell carcinoma of the lung was confirmed cytological or pathological examiation.
2. stage IIIB or IV and reccurent cases after resection.
3. age 20-80 years
4. Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1.
5. tumor with negative or unkown for EGFR senstive mutation.
6. CR, PR, and SD cases after induction platinum doublet.

Key exclusion criteria

they had a concurrent malignancy, uncontrollable complications, severe morbidity; hypersensitivity to therapeutic agents; the possibility of being pregnant, and other conditions such as hepatic inflammation, as judged by the attending physician.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Fumihiro
Middle name
Last name Tanaka

Organization

University of Occupational and Environmental Health

Division name

Second Department of Surgery

Zip code

8078555

Address

Iseigaoka, Yahatanishi-ku

TEL

0936917442

Email

ftanaka@med.uoeh-u.ac.jp


Public contact

Name of contact person

1st name Koji
Middle name
Last name Kuroda

Organization

University of Occupational and Environmental Health

Division name

Second Department of Surgery

Zip code

8078555

Address

Iseigaoka, Yahatanishi-ku

TEL

0936917442

Homepage URL


Email

kuroda-k@med.uoeh-u.ac.jp


Sponsor or person

Institute

University of Occupational and Environmental Health

Institute

Department

Personal name



Funding Source

Organization

University of Occupational and Environmental Health

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Occupational and Environmental Health

Address

1-1 Iseigaoka, Yahatanishi-ku, Kitakyusyu

Tel

093-603-1611

Email

fumi0914@med.uoeh-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

産業医科大学


Other administrative information

Date of disclosure of the study information

2011 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

11

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 06 Month 01 Day

Date of IRB

2011 Year 07 Month 06 Day

Anticipated trial start date

2011 Year 08 Month 01 Day

Last follow-up date

2018 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 06 Month 01 Day

Last modified on

2019 Year 06 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006741


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name